Vivosang, Inc.
Vivosang Inc is an investigational stage biotechnology company focused on developing pegylated human hemoglobin products to enhance oxygen delivery in medical applications, particularly in traumatic hemorrhagic injuries. Their lead product, VS-101, aims to provide targeted oxygen delivery to tissues in need, addressing significant medical needs in emergency and surgical settings.
Industries
N/A
Nr. of Employees
small (1-50)
Vivosang, Inc.
Products
Investigational pegylated hemoglobin-based oxygen carrier
A cell-free human hemoglobin therapeutic, chemically conjugated with polyethylene glycol to provide targeted oxygen delivery to capillaries, designed for rapid oxygenation of ischemic tissues and to be stored at ambient temperature for use in hemorrhagic resuscitation.
Investigational pegylated hemoglobin-based oxygen carrier
A cell-free human hemoglobin therapeutic, chemically conjugated with polyethylene glycol to provide targeted oxygen delivery to capillaries, designed for rapid oxygenation of ischemic tissues and to be stored at ambient temperature for use in hemorrhagic resuscitation.
Services
Research and development activities to advance cell-free hemoglobin oxygen carriers from preclinical evaluation toward clinical investigation, including formulation, analytical characterization, preclinical in vivo testing, and manufacturing readiness.
Research and development activities to advance cell-free hemoglobin oxygen carriers from preclinical evaluation toward clinical investigation, including formulation, analytical characterization, preclinical in vivo testing, and manufacturing readiness.
Expertise Areas
- Hemoglobin-based oxygen therapeutics
- Protein PEGylation and conjugation chemistry
- Preclinical hemorrhage and ischemia models
- Formulation development for ambient-stable biologics
Key Technologies
- Protein PEGylation
- Hemoglobin purification from donor red blood cells
- In vivo hemorrhagic and exchange-transfusion models
- Oxygen-binding and kinetics assays
News & Updates
2023 Military Health Systems Research Symposium
Presentation on 'Novel PEGylated HBOC Bridges Circulatory Function and Oxygen Delivery in Rat Exchange Transfusion.'
2023 Military Health Systems Research Symposium
Presentation on 'Novel PEGylated HBOC Bridges Circulatory Function and Oxygen Delivery in Rat Exchange Transfusion.'